微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 36.32% | -1.49% | 7.9% | 100/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 33.66% | -10.56% | 8.4% | 103/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 31.05% | -16.79% | -14% | 108/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 36.11% | -16.52% | -2.07% | 97/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 36.87% | -16.9% | -2.03% | 100/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 37.63% | -14.13% | 0.85% | 95/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 37.32% | -12.06% | -13.72% | 100/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 43.25% | -1.79% | -2.52% | 87/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 44.37% | -1.23% | 1.23% | 87/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 43.83% | -6.81% | 3.29% | 82/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 42.43% | -8.32% | -3.65% | 93/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 44.04% | -7.16% | -1.97% | 87/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 44.92% | -7.86% | -4.48% | 86/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 47.03% | -12.23% | 1.61% | 80/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 46.28% | -3.67% | -2.42% | 85/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 47.43% | 1.25% | -2.71% | 77/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 48.75% | 3.79% | -9.01% | 80/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 53.58% | 12.09% | 11.52% | 69/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 48.05% | 17.03% | 2.56% | 88/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 46.85% | 14.61% | -0.27% | 79/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 46.97% | 21.98% | -1.74% | 85/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 47.8% | 38.57% | 16.44% | 74/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 41.05% | -9.89% | 0.44% | 109/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 40.88% | -8.56% | 6.15% | 75/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 38.51% | -10.97% | 11.63% | 93/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 34.5% | -18.19% | -24.28% | 68/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 45.56% | 9.72% | 1.91% | 81/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 44.71% | -0.38% | 3.35% | 42/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 43.26% | -4.46% | 2.57% | 54/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 42.17% | -3.5% | 1.56% | 33/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 41.52% | -7.74% | -7.47% | 78/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 44.87% | 0.69% | -0.89% | 29/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 45.27% | 3.17% | 3.6% | 35/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 43.7% | 2.52% | -2.89% | 31/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 45% | -0.98% | 0.98% | 67/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 44.57% | -1.67% | 1.55% | 28/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 43.89% | -0.34% | 2.95% | 37/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 42.63% | -2.67% | -6.21% | 29/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 45.45% | -6.14% | 0.28% | 52/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 45.32% | -6.02% | 2.92% | 22/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 44.04% | -9.22% | 0.55% | 29/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 43.8% | -11.24% | -9.55% | 20/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |